Ali T Arafa

7PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient Groups.

|May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers.

Catherine H Marshall, Ali T Arafa, Ellen Jaeger

|Feb 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality.

Ali T Arafa, Siddhartha Yadav, Catherine H Marshall

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Jan 08, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients.

Ali T Arafa, Megan Ludwig, Onur Tuncer

|Jun 20, 2023
Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case-control study.

Ali T Arafa, Leah R Blader, Karan Ramakrishna

Pageof 2

Frequent Collaborators

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Justin Hwang

2 joint publications

Christine Luo

2 joint publications

Stamatina Fragkogianni